Decision Making in Gynecologic Oncology

Nyhet

Häftad, Engelska, 2026

Av Pedro T. Ramirez, Michael Frumovitz, Nicolo Bizzarri, USA) Ramirez, Pedro T. (Department of Obstetrics and Gynecology, Editor-in-Chief, International Journal of Gynecological Cancer, Houston Methodist Hospital, Neal Cancer Center, Houston, Texas, USA) Frumovitz, Michael (Professor and Chief Patient Experience Officer, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, Italy) Bizzarri, Nicolo, MD, PhD (Catholic University of the Sac, Rome, Pedro T Ramirez

1 239 kr

Kommande

Designed for physicians who are managing women with gynecologic malignancies, Decision Making in Gynecologic Oncology is a practical reference to help guide daily clinical decision making. Organized by cancer type and specific disease for quick reference, each chapter presents key concepts in an algorithmic format, using easy-to-interpret decision trees that visually outline the critical steps and choices involved in patient management. Brief explanatory text accompanies each algorithm, clarifying the significance of important decision points and encouraging systematic, logical thinking throughout the diagnostic and surgical process.

Produktinformation

Utgivningsdatum2026-10-01
Mått216 x 276 x undefined mm
Vikt450 g
FormatHäftad
SpråkEngelska
Antal sidor320
FörlagElsevier Health Sciences
ISBN9780443124808

Tillhör följande kategorier

Gynekologi och obstetrik inom Medicin

Pedro T. Ramirez MD is Professor of Gynecologic Oncology at MD Anderson Cancer Center in Houston, Texas. He has authored and co-authored 264 scientific publications and has written 19 book chapters, monographs, and invited articles. He is also the Editor-in-Chief of the International Journal of Gynecological Cancer. In addition, he is the Director of the Enhanced Recovery After Surgery (ERAS) Gynecologic Oncology Program at MD Anderson Cancer Center. Dr. Ramirez is the Principal Investigator of numerous prospective trials, including the LACC Trial. His areas of research interest include outcomes of minimally invasive surgery in gynecologic cancers and enhanced recovery after surgery implementation pathways.